News | May 19, 2023
KIMS posts Q4FY23 consolidated PAT at Rs. 93.27 Cr
The company has reported total income of Rs. 580.81 crores during the period ended March 31, 2023
The company has reported total income of Rs. 580.81 crores during the period ended March 31, 2023
Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023
Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3%
The company has reported total income of Rs. 604.02 crores during the period ended March 31, 2023
This latest audit re-emphasizes Hikal's commitment towards maintaining the best in class quality, compliance and regulatory standards across our manufacturing sites
The Niti Aayog and the DoP had listed a few factors that were leading to a 10-15% disability factor to be globally competitive
The need is to focus on an enabling framework to bridge the digital divide across countries specifically amongst low-and-middle-income countries
Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security
The company has reported total income of Rs. 149.78 crores during the period ended March 31, 2023
Dr. Reddy's Laboratories has been issued a Form 483 with four observations
Subscribe To Our Newsletter & Stay Updated
